An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Supplements and Featured PublicationsMeasuring Persistency with Drug Therapy in Glaucoma Management
Volume 8
Issue 10 Suppl

© 2023 MJH Life Sciences
AJMC®
All rights reserved.